Medicare Enrolled
Dr. Andrew Beardsley, M.D.
Hematology · Asheville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Beardsley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beardsley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Beardsley
Dr. Andrew Beardsley is a hematology specialist in Asheville, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Beardsley performed 35,556 Medicare services across 2,974 unique beneficiaries.
Between the years covered by Open Payments, Dr. Beardsley received a total of $1,529 from 32 pharmaceutical and/or device companies across 70 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Beardsley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 18% volume in NC
$1,529 industry payments
Medicare Practice Summary
Medicare Utilization ↗35,556
Medicare services
Top 18% in NC for hematology
2,974
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,975 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 13,800 | $43 | $157 |
| Anti-nausea injection (aprepitant) | 5,980 | $1 | $6 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,900 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $18 | $64 |
| Iron infusion (Monoferric) | 1,400 | $16 | $74 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,314 | $36 | $141 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
950 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
908 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
905 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
855 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 660 | $1 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
532 | $92 | $390 |
| Anti-nausea injection (ondansetron/Zofran) | 408 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
312 | $93 | $421 |
| Injection, leucovorin calcium, per 50 mg | 274 | $3 | $14 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
216 | $70 | $210 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
197 | $126 | $550 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
174 | $2 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
142 | $21 | $103 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
137 | $2 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
129 | $10 | $67 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
112 | $11 | $66 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
106 | $60 | $214 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
94 | $7 | $126 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $56 | $277 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
85 | $10 | $44 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $135 | $603 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
73 | $1 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $43 | $208 |
| New patient office visit, complex (60-74 min) | 64 | $161 | $673 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
64 | $43 | $180 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
59 | $47 | $205 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
58 | $52 | $234 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $90 | $308 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
47 | $24 | $135 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
45 | $21 | $164 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
44 | $18 | $83 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
40 | $15 | $65 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
38 | $3 | $11 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 38 | $196 | $1,533 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
34 | $16 | $71 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
34 | $2 | $9 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
33 | $37 | $177 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
31 | $23 | $105 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
30 | $1,082 | $4,447 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
26 | $48 | $368 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $128 | $595 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
22 | $171 | $733 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
22 | $66 | $313 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
22 | $1 | $6 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
21 | $9 | $40 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
19 | $4 | $12 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
17 | $1 | $21 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
15 | $13 | $63 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $126 | $509 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.6% high complexity
80.5% medium
9.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,529
Total received (2019-2024)
Avg $306/year across 5 years
Bottom 48% in NC for hematology
32
Companies
70
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,478 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$514
2023
$456
2022
$252
2021
$150
2019
$157
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$105
Merck Sharp & Dohme LLC
$64
Eisai Inc.
$40
Legend Biotech USA Inc.
$39
AstraZeneca Pharmaceuticals LP
$35
Janssen Biotech, Inc.
$33
Myriad Genetic Laboratories, Inc.
$31
Alexion Pharmaceuticals, Inc.
$30
Astellas Pharma US Inc
$27
Celgene Corporation
$25
Bayer Healthcare Pharmaceuticals Inc.
$21
Stemline Therapeutics Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Kyowa Kirin, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2019-2024) ›
Novartis Pharmaceuticals Corporation
$268
Janssen Biotech, Inc.
$181
Medtronic USA, Inc.
$157
AstraZeneca Pharmaceuticals LP
$85
PFIZER INC.
$70
Merck Sharp & Dohme LLC
$64
Mirati Therapeutics, Inc.
$51
Seagen Inc.
$49
Kyowa Kirin, Inc.
$45
GlaxoSmithKline, LLC.
$43
Incyte Corporation
$42
Eisai Inc.
$40
Legend Biotech USA Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$37
Myriad Genetic Laboratories, Inc.
$31
Alexion Pharmaceuticals, Inc.
$30
E.R. Squibb & Sons, L.L.C.
$28
Astellas Pharma US Inc
$27
Celgene Corporation
$25
AbbVie Inc.
$22
Genmab U.S., Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
Tactile Systems Technology Inc
$20
AVEO Pharmaceuticals, Inc.
$18
Stemline Therapeutics Inc.
$18
Merck Sharp & Dohme Corporation
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Epizyme, Inc.,
$14
Ipsen Biopharmaceuticals, Inc
$14
Spectrum Pharmaceuticals Inc.
$13
ARRAY BIOPHARMA INC
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · CREON · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · FOTIVDA · Flexitouch Plus · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MYRISK · NINLARO · Nubeqa · OJJAARA · OPDIVO · OSTEOCOOL RF ABLATION · Orserdu · PIQRAY · POTELIGEO · PROMACTA · Padcev · Poteligeo · REBLOZYL · ROLVEDON · RYBREVANT · SOMATULINE DEPOT · TABRECTA · TAZVERIK · TUKYSA · Tivdak · ULTOMIRIS · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
10
Per 100K population
3.7
County median income
$70,578
Nearest hospital
MEMORIAL MISSION HOSPITAL AND ASHEVILLE SURGERY CE
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Beardsley is a mixed practice specialist, with above-average Medicare volume (top 18% in NC), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Beardsley experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Beardsley performed 13,800 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beardsley receive payments from pharmaceutical companies?
Yes. Dr. Beardsley received a total of $1,529 from 32 companies across 70 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beardsley's costs compare to other hematologists in Asheville?
Dr. Beardsley's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beardsley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Asheville
Browse hematologists in Asheville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NC
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NC
Which NC hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology